Correlation Between Ascletis Pharma and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascletis Pharma and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Ascletis Pharma and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and Salarius Pharmaceuticals.
Diversification Opportunities for Ascletis Pharma and Salarius Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Ascletis and Salarius is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ascletis Pharma and Salarius Pharmaceuticals
Assuming the 90 days horizon Ascletis Pharma is expected to generate 2.49 times less return on investment than Salarius Pharmaceuticals. But when comparing it to its historical volatility, Ascletis Pharma is 3.55 times less risky than Salarius Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 167.00 in Salarius Pharmaceuticals on October 26, 2024 and sell it today you would earn a total of 106.00 from holding Salarius Pharmaceuticals or generate 63.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 93.65% |
| Values | Daily Returns |
Ascletis Pharma vs. Salarius Pharmaceuticals
Performance |
| Timeline |
| Ascletis Pharma |
| Salarius Pharmaceuticals |
Ascletis Pharma and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ascletis Pharma and Salarius Pharmaceuticals
The main advantage of trading using opposite Ascletis Pharma and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.The idea behind Ascletis Pharma and Salarius Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |